Form D · Other
Capital Rx, Inc.
New York, NY · CIK 0001782959
Offering snapshot reported Sep 26, 2025 · SEC filing
- Reported sold
- $231M Offering amount: $233M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2025 | Initial | $230,820,898 | No comparison | 8 | SEC filing |
| Mar 22, 2024 | Initial | $114,999,999 | No comparison | 1 | SEC filing |
| Mar 22, 2024 | Amendment | $114,999,999 | $0vs Mar 22, 2024 | 1 | SEC filing |
| Jun 13, 2022 | Initial | $105,999,993 | No comparison | 9 | SEC filing |
| Jul 14, 2021 | Initial | $3,480,430 | No comparison | Not reported | SEC filing |
| Jan 5, 2021 | Initial | $31,960,628 | No comparison | 4 | SEC filing |
| Jul 19, 2019 | Initial | $12,382,780 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558942
Source: Form D, filed Sep 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Feby Abraham | Director |
| Laura Alemzadeh | Executive |
| Laleh Alemzadeh | Executive |
| Joseph Alexander | Executive |
| Daniel Delmastro | Director |
| Kevin Hill | Director |
| Mostafa Kamal | Director |
| Mark Kandrysawtz | Director |
| Ryan Kelly | Director |
| Jared Kesselheim | Director |
| A.J. Loiacono | Director, Executive |
| A. J. Loiacono | Director, Executive |
| Holly Maloney | Director |
| Lenard Marcus | Director |
| Robert Mittendorff | Director |
Issuer details
Industry: Other (See others in industry)
Address:
228 Park Avenue S. Suite 87234
New York, NY, 10003
New York, NY, 10003